ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics.
about
Overexpression of Raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence.SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway.Expression of phosphorylated extracellular signal-regulated kinase at the invasive front of hepatic colorectal metastasisComprehensive Molecular Analysis of NSCLC; Clinicopathological AssociationsA serine protease extracted from Trichosanthes kirilowii induces apoptosis via the PI3K/AKT-mediated mitochondrial pathway in human colorectal adenocarcinoma cells.Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.Clinicopathologic Significance of BRAF Mutation and Extracellular Signal Regulated Kinase 1/2 Expression in Patients With a Colorectal AdenocarcinomaLinking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells.Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types.
P2860
Q33275573-4677AA08-18A7-4E31-89DA-DA8BFF475717Q34550828-A29F73AE-CB4B-4256-AC8A-323309D7E6FAQ34779146-571E03E1-E2C2-4500-A10C-A36151BF6AE4Q35042382-771913C8-16A9-4463-9C07-C360F6B5AF3CQ35712214-927BFCDD-554B-496E-9462-7E156DA4AC8EQ38811451-79B8523D-28DE-4031-801B-31AB8B04CE57Q41470030-4EB4D154-3340-4C0A-9567-4AC756DBD350Q41875891-DCFD94AD-C5E7-461A-B0C3-05B3C86F676DQ47231829-74A2BB9F-1450-4CF6-9838-906D0E12777CQ51150179-1FE7F000-FEA2-47CA-831D-A89A6317EF4CQ55259943-C530B727-99C5-49B1-9982-96602E6979B7
P2860
ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
ERK/pERK expression and B-raf ...... opathological characteristics.
@ast
ERK/pERK expression and B-raf ...... opathological characteristics.
@en
type
label
ERK/pERK expression and B-raf ...... opathological characteristics.
@ast
ERK/pERK expression and B-raf ...... opathological characteristics.
@en
prefLabel
ERK/pERK expression and B-raf ...... opathological characteristics.
@ast
ERK/pERK expression and B-raf ...... opathological characteristics.
@en
P2093
P2860
P356
P1476
ERK/pERK expression and B-raf ...... copathological characteristics
@en
P2093
Angeliki Stamatelli
Efstratios Patsouris
Fanie Gigelou
George Agrogiannis
Georgia Levidou
Maria Karlou
Nikolaos Kavantzas
Nikolaos V Michalopoulos
Penelope Korkolopoulou
Polyanthi Papanastasiou
P2860
P2888
P356
10.1186/1477-7819-10-47
P577
2012-02-29T00:00:00Z
P5875
P6179
1030854811